Home drug plans

Keyword: drug plans

388 results found

While the concept behind the federal government’s universal pharmacare plan is well intentioned, the program would make a larger impact for employers by focusing on high-cost and specialty drugs, says Pam Martin, vice-president and senior consultant at Baynes & White Inc. In theory, the way that the government is rolling out the program in small […]

Copyright_irinkavasilinka_123RF

As more insurers turn to preferred pharmacy networks to decrease costs, their efforts are being met with some resistance by plan members who may be finding it difficult and inconvenient to switch pharmacy providers. In January, Manulife Financial Corp.’s move to a preferred pharmacy network with Loblaw Cos. Ltd.’s Shoppers Drug Mart was met with […]

Is your organization leading the way in transforming policies and programs to meet the evolving needs of employees? Are you stepping up your financial wellness initiatives to help employees through today’s difficult economic reality? Are you going the extra mile to support your employees’ mental health or implementing an award-worthy diversity, equity and inclusion strategy? […]

  • By: Staff
  • April 30, 2024 April 30, 2024
  • 09:00

In 2023, diabetes medications remained the leading drug category for eligible private insurance claims for the second consecutive year, according to Telus Health’s annual drug trends report. The report, based on claims data from more than 15 million plan members in 2023, found the growing prevalence of diabetes, along with expanded heart failure treatment indications and […]

  • By: Staff
  • April 24, 2024 April 23, 2024
  • 09:00
Copyright_olegback_123RF

An article on considerations for plan sponsors ahead of the rollout of a new generation of obesity drugs was the most-read article on BenefitsCanada.com. Here are the top five human resources, benefits, pension and investment stories of the past week: 1. What plan sponsors should know ahead of rollout of new obesity drugs in Canada 2. What’s […]

  • By: Staff
  • April 5, 2024 April 4, 2024
  • 09:00
Copyright_Aleksandr Kalugin_123RF

While preferred pharmacy networks have been around for nearly a decade, most benefits plan members aren’t aware that these arrangements have become standard, says Suzanne Lepage, a private health plan strategist. Preferred provider networks are common arrangements that businesses across a variety of industries enter into to help deliver consistent value, quality and cost containment, said the Canadian Life […]

Several stakeholders from the benefits sector are partnering to form the Smart Health Benefits Coalition, an advocacy group that aims to strengthen the health-care system and address longstanding gaps in care. The federal government will release the framework for its pharmacare program on March 1 and the coalition — comprised of representatives from Gallagher, Benefits Alliance, GroupHEALTH, Hub International Ltd., […]

An article on the Ontario Court of Appeal’s affirmation of a $1.5 million punitive damages award was the most-read article on BenefitsCanada.com this week. Here are the top five human resources, benefits, pensions and investment articles of the past week: 1. Court of Appeal upholds $1.5 million punitive damages award in LTD claims case 2. N.B. transferring 5 public […]

  • By: Staff
  • February 9, 2024 February 8, 2024
  • 09:00
Copyright_peopleimages12_123RF

Amid an increase in diabetes diagnoses among Canadians, pharmacists can play a greater role in employers’ and private payers’ chronic disease prevention and management strategies given their increasing scope of practice, said representatives for Health Solutions by Shoppers, during a webinar hosted by Benefits Canada and sponsored by Health Solutions by Shoppers in January. As […]

The federal minister in charge of promoting competition says he’s concerned about a deal between Manulife Financial Corp. and Loblaw Cos. Ltd. that restricts patients from filling prescriptions for specialty drugs at other pharmacies under their insurance plans. Industry Minister François-Philippe Champagne said Wednesday the government is reviewing the arrangement, which affects around 260 medications […]